Apogem Capital, a leading private markets investor, has announced the final close of Apogem Secondary Fund VII at its $1.43 billion hard cap. Including employee commitments, the Fund raised over $1.45 billion, exceeding its $1 billion target and more than doubling the size of its predecessor fund.

ASF VII pursues the firm’s established strategy of building a diversified portfolio of GP-led and LP secondary transactions across the North American middle market. Apogem has a longstanding focus on the segment and a well-established track record as a sole buyer in LP secondaries and as a lead or co-lead investor in GP-led transactions.

Read full press release here.